Physiogenex at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Physiogenex brings 2 presentations to ObesityWeek 2026 in National Harbor. Its program centres on metabolic studies of semaglutide and related weight-loss drugs in obese hamsters. One study compares the benefits of semaglutide, tirzepatide and retatrutide, and another uses individual metabolic phenotyping to capture the acute effects of semaglutide.

OrganizationObesityWeek 2026 Attendance
Preclinical tools & services
Preclinical contract research company specializing in metabolic and cardiometabolic disease models.

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Physiogenex

Tell us what you sell and we’ll find the people at Physiogenex most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction